Price movement over the last 24 hours
AFLAC Incorporated vs Barclays PLC — how do they compare? AFLAC Incorporated trades at $121.27 (market cap $61.84B), while Barclays PLC trades at $26.73 (market cap $91.89B). The key difference: Barclays PLC is the larger of the two by market cap, and AFLAC Incorporated pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AFL | BCS | |
|---|---|---|
Market Cap | $61.84B | $91.89B |
Sector | Financials | Financials |
52-Week High | $121.49 | $28.41 |
52-Week Low | $98.09 | $18.31 |
Enterprise Value | $70.50B | — |
Dividend Yield | 2.01% | 1.67% |
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
Barclays PLC (BCS) trades at $27.41, down 1.3% today but near its 52-week high of $28.43. The stock shows strong technical momentum with a bullish moving average signal, though RSI levels indicate potential overbought conditions. Fundamentally, the company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $0.76 exceeding expectations, and maintains a healthy net income margin of 24.5%. Revenue growth has been steady, climbing to $29.14B in 2025.
The outlook remains positive given analyst consensus favoring Buy ratings (68%) and improving cash flow trends, but risks include ongoing securities litigation and sensitivity to interest rate changes. Valuation metrics like a P/E of 12.4 and P/B of 0.95 suggest potential upside if earnings momentum continues, though investors should weigh legal overhangs against fundamental strength.
Trailing returns across standard periods
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →